Physicians' opinions and experiences of the Pharmaceutical Benefits Reform

Scandinavian Journal of Public Health

Volumn 34, Issue 6, 2006, Pages 654-659

  Andersson, Karolina ^a   Jörgensen, Tove ^a   Carlsten, Anders ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

generic substitution; healthcare reform; opinions experiences; Pharmaceutical Benefits Reform; physicians

Indexed keywords

DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTRACT; CONTROLLED STUDY; COST CONTROL; DRUG COST; DRUG INFORMATION; DRUG LEGISLATION; EMPLOYEE; EMPLOYER; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MONEY; PHARMACY; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE PRACTICE; PROBABILITY; QUESTIONNAIRE; RANDOM SAMPLE; REIMBURSEMENT; SWEDEN; WORK EXPERIENCE; WORKPLACE;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; DRUG COSTS; DRUGS, GENERIC; FEMALE; FOCUS GROUPS; HEALTH CARE REFORM; HOSPITALISTS; HUMANS; INSURANCE, HEALTH; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PHYSICIANS, FAMILY; PHYSICIANS, WOMEN; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; SWEDEN;

EID: 33751542137     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1080/14034940600551111     Document Type: Article

References (16)

1. Ess S.M., Schneeweiss S., Szucs T.D. European healthcare policies for controlling drug expenditure. Pharmacoeconomics 2003;21:89-103.
2. Hoffmann M. Drug reform in Sweden: Major changes for patients, doctors and healthcare managers. Hospital—the Official Journal of the European Association of Hospital Managers 2004.
3. Act (2002:160) on Pharmaceutical Benefits, etc. SFS 2002: 160. 2002.
4. Ordinance (2002:687) on Pharmaceutical Benefits, etc. SFS 2002:687. 2002.
5. Lewis J.M., Marjoribanks T. The impact of financial constraints and incentives on professional autonomy. Int J Health Plann Manage 2003;18:49-61.
6. Marjoribanks T., Lewis J.M. Reform and autonomy: Perceptions of the Australian general practice community. Soc Sci Med 2003; 56:2229-2239.
7. Whynes D.K., Baines D.L. Primary care physicians’ attitudes to health care reform in England. Health Policy 2002;60: 111-132.
8. Wilf—Miron R., Rotstein Z., Noy S., Turjeman A., et al. Newly implemented health system reform in Israel: Physicians’ attitudes. Health Policy 1999;49:137-147.
9. Hanning M., Spangberg U.W. Maximum waiting time — a threat to clinical freedom? Implementation of a policy to reduce waiting times. Health Policy 2000;52:15-32.
10. Hunter D.J., Shortt S.E., Walker P.M., Godwin M. Family physician views about primary care reform in Ontario: A postal questionnaire. BMC Fam Pract 2004;5:2.
11. Rubak S.L., Andersen M.L., Mainz J., Olesgaard P., et al. [How do practitioners evaluate the newly introduced system of substituting prescriptions?]. Ugeskr Laeger 2000;162:6070-3.
12. Tilyard M.W., Dovey S.M., Rosenstreich D. General practitioners’ views on generic medication and substitution. N Z Med J 1990;103:318-320.
13. Krueger R.A., Casey M.A. Focus groups: A practical guide for applied research. 3rd ed. Thousand Oaks, CA: Sage Publications; 2000.
14. MacPherson I., Bisset A. Not another questionnaire!: Eliciting the views of general practitioners. Fam Pract 1995;12:335-8.
15. Brust M., Hawkins C.F., Grayson D. Physicians’ attitudes toward generic drug substitution by pharmacists. Tex Med 1990;86:45-49.
16. Andersson K., Sonesson C., Petzold M., Carlsten A., et al. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol Drug Saf 2005;14:341-8.